EXHIBIT 10.2
Confidential Materials omitted and filed separately with the
Securities and Exchange Commission. Double asterisks denote omissions.
NSN 7540-01-152-8070 STANDARD FORM 30 (REV. 10-83)
PREVIOUS EDITION UNUSABLE 30-105 Prescribed by GSA
FAR (48 CFR) 53.243
1. | Decrease the number of doses for SubCLIN 2002 by [**] from [**]to [**]. |
2. | Decrease the cost and funding of SubCLIN 2002 by $[**] from $[**] to $[**]. |
3. | Add SubCLIN 2003 to cover the cost to purchase [**] doses at a lower rate of $[**]. |
4. | Increase and fund [**] doses on SubCLIN 2003 in the amount of $[**]. |
All changes will occur at no additional cost to the Government.
Section B – Supplies/Services
Option 1 Items
ITEM | SUPPLIES / SERVICES | QTY / UNIT | UNIT PRICE | EXTENDED PRICE | ||||||
2002 | BioThrax [**] product [**] upon date of delivery: [**] product at a unit price of $[**] Delivery Address: Contractor's Facility Delivery to be NLT [**] | [**] Doses | $ | [ | **] | $ | [ | **] | ||
Line(s) Of Accounting: 939ZWUX 2642 2018 75-X-0956 5664711101 $[**] |
ITEM | SUPPLIES / SERVICES | QTY / UNIT | UNIT PRICE | EXTENDED PRICE | ||||||
2003 | BioThrax [**] product [**] upon date of delivery: [**] product at a unit price of $[**] Delivery Address: Contractor's Facility Delivery to be NLT [**] | [**] Doses | $ | [ | **] | $ | [ | **] | ||
Line(s) Of Accounting: 939ZWUX 2642 2018 75-X-0956 5664711101 $[**] |